Antibiotic Exposure Leads to Reduced Phage Susceptibility in Vancomycin Intermediate Staphylococcus aureus (VISA)
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibiotic Exposure Leads to Reduced Phage Susceptibility in Vancomycin Intermediate Staphylococcus aureus (VISA)
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 66, Issue 7, Pages -
Publisher
American Society for Microbiology
Online
2022-06-16
DOI
10.1128/aac.02247-21
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genes Influencing Phage Host Range in Staphylococcus aureus on a Species-Wide Scale
- (2021) Abraham G. Moller et al. mSphere
- A systematic review of phage therapy applied to bone and joint infections: an analysis of success rates, treatment modalities and safety
- (2021) Joseph Genevière et al. EFORT Open Reviews
- ICTV Virus Taxonomy Profile: Herelleviridae
- (2020) Jakub Barylski et al. JOURNAL OF GENERAL VIROLOGY
- Safety of bacteriophage therapy in severe Staphylococcus aureus infection
- (2020) Aleksandra Petrovic Fabijan et al. Nature Microbiology
- Phage Therapy for Limb-threatening Prosthetic Knee Klebsiella pneumoniae Infection: Case Report and In Vitro Characterization of Anti-biofilm Activity
- (2020) Edison J Cano et al. CLINICAL INFECTIOUS DISEASES
- Design and Preclinical Development of a Phage Product for the Treatment of Antibiotic-Resistant Staphylococcus aureus Infections
- (2019) Susan Lehman et al. Viruses-Basel
- Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria
- (2019) Kaitlyn E. Kortright et al. Cell Host & Microbe
- Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus
- (2019) Mian Li Ooi et al. JAMA Otolaryngology-Head & Neck Surgery
- Bacteriophage Application for Difficult-to-treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment Protocol
- (2019) Onsea et al. Viruses-Basel
- Correlation of Host Range Expansion of Therapeutic Bacteriophage Sb-1 with Allele State at a Hypervariable Repeat Locus
- (2019) Kirill V. Sergueev et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Metagenome analysis of Russian and Georgian Pyophage cocktails and a placebo-controlled safety trial of single phage versus phage cocktail in healthy Staphylococcus aureus carriers
- (2018) Shawna McCallin et al. ENVIRONMENTAL MICROBIOLOGY
- The incidence of MRSA infections in the United States: is a more comprehensive tracking system needed?
- (2017) Kevin T. Kavanagh et al. Antimicrobial Resistance and Infection Control
- Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus
- (2016) Yuki Katayama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- rRNA Operon Copy Number Can Explain the Distinct Epidemiology of Hospital-Associated MRSA
- (2016) A.C. Fluit et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A non-invasive method for studying viral DNA delivery to bacteria reveals key requirements for phage SPP1 DNA entry in Bacillus subtilis cells
- (2016) Sofia Fernandes et al. VIROLOGY
- Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh
- (2016) Shafiqul Alam Sarker et al. EBioMedicine
- Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
- (2015) Steven Y. C. Tong et al. CLINICAL MICROBIOLOGY REVIEWS
- Clinical Implications of Vancomycin Heteroresistant and Intermediately SusceptibleStaphylococcus aureus
- (2015) Diane M. Gomes et al. PHARMACOTHERAPY
- Mechanism of Reduced Vancomycin Susceptibility Conferred bywalKMutation in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strain MW2
- (2014) Jinfeng Hu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combined Use of Bacteriophage K and a Novel Bacteriophage To Reduce Staphylococcus aureus Biofilm Formation
- (2014) D. R. Alves et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Dissecting Vancomycin-Intermediate Resistance in Staphylococcus aureus Using Genome-Wide Association
- (2014) Md Tauqeer Alam et al. Genome Biology and Evolution
- Penicillin-binding protein 2a of methicillin-resistantStaphylococcus aureus
- (2014) Jennifer Fishovitz et al. IUBMB LIFE
- Mechanisms of vancomycin resistance in Staphylococcus aureus
- (2014) Susana Gardete et al. JOURNAL OF CLINICAL INVESTIGATION
- Vancomycin-intermediate resistance in Staphylococcus aureus
- (2014) Keiichi Hiramatsu et al. Journal of Global Antimicrobial Resistance
- Clinical Outcomes in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bloodstream Infection
- (2013) Anthony M. Casapao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases
- (2013) Alfonso Zecconi et al. IMMUNOLOGY LETTERS
- The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA
- (2013) Benjamin P. Howden et al. INFECTION GENETICS AND EVOLUTION
- Patterning and Lifetime of Plasma Membrane-Localized Cellulose Synthase Is Dependent on Actin Organization in Arabidopsis Interphase Cells
- (2013) A. Sampathkumar et al. PLANT PHYSIOLOGY
- The Phage Lytic Proteins from the Staphylococcus aureus Bacteriophage vB_SauS-phiIPLA88 Display Multiple Active Catalytic Domains and Do Not Trigger Staphylococcal Resistance
- (2013) Lorena Rodríguez-Rubio et al. PLoS One
- Genetic Variation in the Staphylococcus aureus 8325 Strain Lineage Revealed by Whole-Genome Sequencing
- (2013) Kristoffer T. Bæk et al. PLoS One
- Safety analysis of a Russian phage cocktail: From MetaGenomic analysis to oral application in healthy human subjects
- (2013) Shawna McCallin et al. VIROLOGY
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- A novel bacteriophage Tail-Associated Muralytic Enzyme (TAME) from Phage K and its development into a potent antistaphylococcal protein
- (2011) Vivek Paul et al. BMC MICROBIOLOGY
- A widespread family of bacterial cell wall assembly proteins
- (2011) Yoshikazu Kawai et al. EMBO JOURNAL
- The Staphylococcus aureus Two-Component Regulatory System, GraRS, Senses and Confers Resistance to Selected Cationic Antimicrobial Peptides
- (2011) Soo-Jin Yang et al. INFECTION AND IMMUNITY
- Wall Teichoic Acid-Dependent Adsorption of Staphylococcal Siphovirus and Myovirus
- (2011) G. Xia et al. JOURNAL OF BACTERIOLOGY
- Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens
- (2011) Leila Kvachadze et al. Microbial Biotechnology
- Heterogeneous Vancomycin Resistance in Staphylococcus Aureus: A Review of Epidemiology, Diagnosis, and Clinical Significance
- (2010) Star L Rong et al. ANNALS OF PHARMACOTHERAPY
- The SPO1-related bacteriophages
- (2010) Jochen Klumpp et al. ARCHIVES OF VIROLOGY
- Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
- (2010) B. P. Howden et al. CLINICAL MICROBIOLOGY REVIEWS
- VanA-Type Vancomycin-Resistant Staphylococcus aureus
- (2009) B. Perichon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of Transcription in Staphylococcus aureus by a Primary Sigma Factor-Binding Polypeptide from Phage G1
- (2009) M. Dehbi et al. JOURNAL OF BACTERIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started